Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy

Elizabeth W Thompson1,2, Srikant Kamesh Iyer3, Michael P Solomon1

  • 1Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA.

Insights

T1ρ imaging shows moderate correlation with late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM) patients. Both T1ρ and T1 relaxation times, along with extracellular volume (ECV), are elevated in HCM patients, suggesting T1ρ

Area of Science:

  • Cardiovascular Magnetic Resonance Imaging
  • Cardiac Pathology
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HCM) involves left ventricular wall thickening, cardiomyocyte hypertrophy, and fibrosis.
  • Current risk stratification methods include late gadolinium enhancement (LGE), native T1, and extracellular volume (ECV) imaging.
  • T1ρ imaging, a technique less sensitive to magnetic field inhomogeneities, offers a potential alternative for assessing cardiac tissue characteristics.

Purpose of the Study:

  • To evaluate the utility of T1ρ cardiovascular magnetic resonance (CMR) imaging in patients with HCM.
  • To compare T1ρ imaging with established CMR techniques like native T1, extracellular volume (ECV), and late gadolinium enhancement (LGE).
  • To assess differences in T1ρ, T1, and ECV between HCM patients and healthy controls.

Main Methods:

  • Recruited 40 HCM patients and 10 matched healthy controls for cardiovascular magnetic resonance (CMR) imaging at 1.5T.
  • Acquired short-axis T1 and T1ρ images, along with gadolinium-enhanced LGE images covering the entire heart.
  • Quantified percent enhancement area using full-width half-maximum thresholding for LGE, T1, and T1ρ, and calculated ECV.

Main Results:

  • T1ρ and T1 percent enhancement areas showed moderate correlation with LGE percent enhancement area (Spearman's rho = 0.48, p<0.001 and rho = 0.61, p<1e-5, respectively).
  • HCM patients exhibited significantly longer T1 and T1ρ relaxation times compared to controls across all LGE categories (p<0.001).
  • HCM patients demonstrated significantly higher ECV compared to controls (p<0.01), with lower ECV in LGE-negative slices.

Conclusions:

  • T1ρ imaging demonstrates a moderate correlation with LGE in quantifying hyperenhancement areas in HCM.
  • Elevated T1, T1ρ, and ECV in HCM patients compared to controls suggest potential for T1ρ in disease assessment.
  • Further research is warranted to explore the prognostic value of T1ρ imaging in HCM patient management.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
155
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.0K